The implant is the first of its kind to be approved for use in the country and is used to treat avascular necrosis of the talus, according to a Feb. 17 news release. It is a custom 3D-printed implant that allows patients to regain motion and reduces pain.
“Avascular necrosis of the talus is extremely painful and debilitating for these patients,” said Greg Kowalczyk, president of Additive Orthopaedics. “Surgical treatment options are below-the-knee amputation or joint fusion, which results in loss of motion of the ankle and can have poor outcomes. The Patient Specific Talus Spacer is another example of how 3D-printed devices can improve the standard of care.”
More articles on orthopedics:
Massachusetts, Rhode Island practices to forge 60-plus physician group
3 spine surgeons debut high-speed drills with Mazor robot
Former Medtronic exec to lead Zimmer Biomet’s spine spinoff
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
